{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:41:57Z","timestamp":1770136917175,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jmig.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T20:45:46Z","timestamp":1482180346000},"page":"230-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Role of Fallopian Tubes in the Development of Ovarian Cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Camila","family":"Corzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.","family":"Iniesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Guadalupe","family":"Patrono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro T.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmig.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00404-013-3114-3","article-title":"The heterogeneity of ovarian cancer","volume":"289","author":"Meinhold-Heerlein","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jmig.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","article-title":"The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Meinhold-Heerlein","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jmig.2016.12.007_bib4","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jmig.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.jmig.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib8","article-title":"Epidemiology of epithelial ovarian cancer","author":"Webb","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2015.06.017","article-title":"Why have ovarian cancer mortality rates declined? Part I. Incidence","volume":"138","author":"Sopik","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib10","unstructured":"Howlader NA, Krapcho M, Miller D, et\u00a0al. SEER Cancer Statistics Review, 1975\u20132013. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2013. Accessed January 23, 2017."},{"key":"10.1016\/j.jmig.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"e0156661","DOI":"10.1371\/journal.pone.0156661","article-title":"Modeling the dynamics of high-grade serous ovarian cancer progression for transvaginal ultrasound-based screening and early detection","volume":"11","author":"Botesteanu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmig.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in\u00a0BRCA1\/2 mutation carriers: an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmig.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ygyno.2013.06.029","article-title":"Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis","volume":"130","author":"Reade","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-157-11-201212040-00539","article-title":"Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmig.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/AOG.0b013e31821477db","article-title":"Committee Opinion No. 477. The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin No. 103. Hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmig.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmig.2016.12.007_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prevent Res"},{"key":"10.1016\/j.jmig.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 2","key":"10.1016\/j.jmig.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ijgo.2015.06.007","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"131","author":"Berek","year":"2015","journal-title":"Int J Gynecol Obstet"},{"issue":"Suppl 10","key":"10.1016\/j.jmig.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib26","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1038\/ncomms11620","article-title":"Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution","volume":"7","author":"Bartlett","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmig.2016.12.007_bib30","first-page":"848","article-title":"Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during\u00a0benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2016.00108","article-title":"Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention","volume":"6","author":"George","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmig.2016.12.007_bib37","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/onc.2015.288","article-title":"YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells","volume":"35","author":"Hua","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jmig.2016.12.007_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.jmig.2016.12.007_bib41","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/pin.12419","article-title":"Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer","volume":"66","author":"Nishida","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.jmig.2016.12.007_bib43","doi-asserted-by":"crossref","first-page":"e1000114","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmig.2016.12.007_bib44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jmig.2016.12.007_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jmig.2016.12.007_bib47","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmig.2016.12.007_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2016.12.007_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jmig.2016.12.007_bib50","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmig.2016.12.007_bib51","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am J Surg"},{"key":"10.1016\/j.jmig.2016.12.007_bib52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in brca1 or brca2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jmig.2016.12.007_bib53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib54","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2016.12.007_bib55","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib56","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmig.2009.12.016","article-title":"Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health","volume":"17","author":"Parker","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40661-015-0014-1","article-title":"Opportunistic salpingectomy for ovarian cancer prevention","volume":"2","author":"Hanley","year":"2015","journal-title":"Gynecol Oncol Res Pract"},{"key":"10.1016\/j.jmig.2016.12.007_bib60","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2016.12.007_bib62","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2016.12.007_bib63","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajog.2016.07.055","article-title":"Growth in salpingectomy rates in the United States since 2000","volume":"215","author":"Hicks-Courant","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib64","article-title":"The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States","author":"Hanley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2016.12.007_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12935-016-0354-x","article-title":"Cytologic studies of the fallopian tube in patients\u00a0undergoing salpingo-oophorectomy","volume":"16","author":"Chen","year":"2016","journal-title":"Cancer Cell Int"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465016312158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465016312158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T19:51:00Z","timestamp":1536177060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465016312158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1553465016312158"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2016.12.007","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Fallopian Tubes in the Development of Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}